Singapore, May 31 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More
Singapore, May 31 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More
Singapore, May 31 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More
Singapore, May 31 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... Read More
Singapore, May 31 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125753) titled 'Research on the effects and mechanisms of KLF5-GPNMB on postoperative deli... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125756) titled 'A Randomized, Controlled, Open-Label, Single-Center Clinical Trial of Aipl... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125760) titled 'Low-Dose Cyclosporine Combined with Eltrombopag in Patients with Primary I... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125755) titled 'Study on the role of MDH2 lactylation in tumor microcirculation abnormalit... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125759) titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clini... Read More